Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 3
1994 1
1995 3
1997 2
1998 2
1999 1
2001 2
2002 3
2003 1
2005 3
2006 5
2007 3
2008 2
2013 1
2014 1
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Results by year
Filters applied: . Clear all
Page 1
Expression of tachykinin NK2 receptor mRNA in human brain.
Bensaid M, Faucheux BA, Hirsch E, Agid Y, Soubrié P, Oury-Donat F. Bensaid M, et al. Among authors: oury donat f. Neurosci Lett. 2001 Apr 27;303(1):25-8. doi: 10.1016/s0304-3940(01)01685-8. Neurosci Lett. 2001. PMID: 11297815
SR 120819A, an orally-active and selective neuropeptide Y Y1 receptor antagonist.
Serradeil-Le Gal C, Valette G, Rouby PE, Pellet A, Oury-Donat F, Brossard G, Lespy L, Marty E, Neliat G, de Cointet P, et al. Serradeil-Le Gal C, et al. Among authors: oury donat f. FEBS Lett. 1995 Apr 3;362(2):192-6. doi: 10.1016/0014-5793(95)00230-7. FEBS Lett. 1995. PMID: 7720871 Free article.
SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (1) binding and functional profile.
Biton B, Bergis OE, Galli F, Nedelec A, Lochead AW, Jegham S, Godet D, Lanneau C, Santamaria R, Chesney F, Léonardon J, Granger P, Debono MW, Bohme GA, Sgard F, Besnard F, Graham D, Coste A, Oblin A, Curet O, Vigé X, Voltz C, Rouquier L, Souilhac J, Santucci V, Gueudet C, Françon D, Steinberg R, Griebel G, Oury-Donat F, George P, Avenet P, Scatton B. Biton B, et al. Among authors: oury donat f. Neuropsychopharmacology. 2007 Jan;32(1):1-16. doi: 10.1038/sj.npp.1301189. Epub 2006 Oct 4. Neuropsychopharmacology. 2007. PMID: 17019409
Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats.
Gary-Bobo M, Elachouri G, Gallas JF, Janiak P, Marini P, Ravinet-Trillou C, Chabbert M, Cruccioli N, Pfersdorff C, Roque C, Arnone M, Croci T, Soubrié P, Oury-Donat F, Maffrand JP, Scatton B, Lacheretz F, Le Fur G, Herbert JM, Bensaid M. Gary-Bobo M, et al. Among authors: oury donat f. Hepatology. 2007 Jul;46(1):122-9. doi: 10.1002/hep.21641. Hepatology. 2007. PMID: 17526015
SR 46559A: a novel and potent muscarinic compound with no cholinergic syndrome.
Kan JP, Steinberg R, Oury-Donat F, Michaud JC, Thurneyssen O, Terranova JP, Gueudet C, Souilhac J, Brodin R, Boigegrain R, et al. Kan JP, et al. Among authors: oury donat f. Psychopharmacology (Berl). 1993;112(2-3):219-27. doi: 10.1007/BF02244914. Psychopharmacology (Berl). 1993. PMID: 7871023
Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia.
Boulay D, Pichat P, Dargazanli G, Estenne-Bouhtou G, Terranova JP, Rogacki N, Stemmelin J, Coste A, Lanneau C, Desvignes C, Cohen C, Alonso R, Vigé X, Biton B, Steinberg R, Sevrin M, Oury-Donat F, George P, Bergis O, Griebel G, Avenet P, Scatton B. Boulay D, et al. Among authors: oury donat f. Pharmacol Biochem Behav. 2008 Nov;91(1):47-58. doi: 10.1016/j.pbb.2008.06.009. Epub 2008 Jun 24. Pharmacol Biochem Behav. 2008. PMID: 18621075
28 results